Market Segmentation
- Canada Nuclear Medicine Product Outlook (Revenue, USD Million, 2018 - 2030)
- Diagnostic Products
- SPECT
- TC-99m
- TL-201
- GA-67
- I-123
- Other SPECT Products
- PET
- F-18
- SR-82/RB-82
- Other PET Products
- SPECT
- Therapeutic Products
- Alpha Emitters
- RA-223
- Others
- Beta Emitters
- I-131
- Y-90
- SM-153
- Re-186
- Lu-117
- Other Beta Emitters
- Brachytherapy
- Cesium-131
- Iodine-125
- Palladium-103
- Iridium-192
- Other Brachytherapy Products
- Alpha Emitters
- Diagnostic Products
- Canada Nuclear Medicine Application Outlook (Revenue, USD Million, 2018 - 2030)
- Cardiology
- Neurology
- Oncology
- Thyroid
- Lymphoma
- Bone Metastasis
- Endocrine Tumor
- Others
- Canada Nuclear Medicine End-use Outlook (Revenue, USD Million, 2018 - 2030)
- Hospitals and Clinics
- Diagnostic Centers
- Others
- Canada Nuclear Medicine Province Outlook (Revenue, USD Million, 2018 - 2030)
- Alberta
- Alberta Nuclear Medicine Market, By Product, 2018 - 2030 (USD Million)
- Diagnostic Products
- SPECT
- TC-99m
- TL-201
- GA-67
- I-123
- Other SPECT products
- PET
- F-18
- SR-82/RB-82
- Other PET Products
- SPECT
- Therapeutic Products
- Alpha Emitters
- RA-223
- Others
- Beta Emitters
- I-131
- Y-90
- SM-153
- Re-186
- Lu-117
- Other Beta Emitters
- Brachytherapy
- Cesium-131
- Iodine-125
- Palladium-103
- Iridium-192
- Other Brachytherapy Products
- Alpha Emitters
- Diagnostic Products
- Alberta Nuclear Medicine Market, By Application, 2018 - 2030 (USD Million)
- Cardiology
- Neurology
- Oncology
- Thyroid
- Lymphoma
- Bone Metastasis
- Endocrine Tumor
- Others
- Alberta Nuclear Medicine Market, By End Use, 2018 - 2030 (USD Million)
- Hospitals & Clinics
- Diagnostic Centers
- Others
- Alberta Nuclear Medicine Market, By Product, 2018 - 2030 (USD Million)
- Saskatchewan
- Saskatchewan Nuclear Medicine Market, By Product, 2018 - 2030 (USD Million)
- Diagnostic Products
- SPECT
- TC-99m
- TL-201
- GA-67
- I-123
- Other SPECT products
- PET
- F-18
- SR-82/RB-82
- Other PET Products
- SPECT
- Therapeutic Products
- Alpha Emitters
- RA-223
- Others
- Beta Emitters
- I-131
- Y-90
- SM-153
- Re-186
- Lu-117
- Other Beta Emitters
- Brachytherapy
- Cesium-131
- Iodine-125
- Palladium-103
- Iridium-192
- Other Brachytherapy Products
- Alpha Emitters
- Diagnostic Products
- Saskatchewan Nuclear Medicine Market, By Application, 2018 - 2030 (USD Million)
- Cardiology
- Neurology
- Oncology
- Thyroid
- Lymphoma
- Bone Metastasis
- Endocrine Tumor
- Others
- Saskatchewan Nuclear Medicine Market, By End Use, 2018 - 2030 (USD Million)
- Hospitals & Clinics
- Diagnostic Centers
- Others
- Saskatchewan Nuclear Medicine Market, By Product, 2018 - 2030 (USD Million)
- Manitoba
- Manitoba Nuclear Medicine Market, By Product, 2018 - 2030 (USD Million)
- Diagnostic Products
- SPECT
- TC-99m
- TL-201
- GA-67
- I-123
- Other SPECT products
- PET
- F-18
- SR-82/RB-82
- Other PET Products
- SPECT
- Therapeutic Products
- Alpha Emitters
- RA-223
- Others
- Beta Emitters
- I-131
- Y-90
- SM-153
- Re-186
- Lu-117
- Other Beta Emitters
- Brachytherapy
- Cesium-131
- Iodine-125
- Palladium-103
- Iridium-192
- Other Brachytherapy Products
- Alpha Emitters
- Diagnostic Products
- Manitoba Nuclear Medicine Market, By Application, 2018 - 2030 (USD Million)
- Cardiology
- Neurology
- Oncology
- Thyroid
- Lymphoma
- Bone Metastasis
- Endocrine Tumor
- Others
- Manitoba Nuclear Medicine Market, By End Use, 2018 - 2030 (USD Million)
- Hospitals & Clinics
- Diagnostic Centers
- Others
- Manitoba Nuclear Medicine Market, By Product, 2018 - 2030 (USD Million)
- Rest of Canada
- Rest of Canada Nuclear Medicine Market, By Product, 2018 - 2030 (USD Million)
- Diagnostic Products
- SPECT
- TC-99m
- TL-201
- GA-67
- I-123
- Other SPECT products
- PET
- F-18
- SR-82/RB-82
- Other PET Products
- SPECT
- Therapeutic Products
- Alpha Emitters
- RA-223
- Others
- Beta Emitters
- I-131
- Y-90
- SM-153
- Re-186
- Lu-117
- Other Beta Emitters
- Brachytherapy
- Cesium-131
- Iodine-125
- Palladium-103
- Iridium-192
- Other Brachytherapy Products
- Alpha Emitters
- Diagnostic Products
- Rest of Canada Nuclear Medicine Market, By Application, 2018 - 2030 (USD Million)
- Cardiology
- Neurology
- Oncology
- Thyroid
- Lymphoma
- Bone Metastasis
- Endocrine Tumor
- Others
- Rest of Canada Nuclear Medicine Market, By End Use, 2018 - 2030 (USD Million)
- Hospitals & Clinics
- Diagnostic Centers
- Others
- Rest of Canada Nuclear Medicine Market, By Product, 2018 - 2030 (USD Million)
- Alberta
Report content
Qualitative Analysis
- Industry overview
- Industry trends
- Market drivers and restraints
- Market size
- Growth prospects
- Porter’s analysis
- PESTEL analysis
- Key market opportunities prioritized
- Competitive landscape
- Company overview
- Financial performance
- Product benchmarking
- Latest strategic developments
Quantitative Analysis
- Market size, estimates, and forecast from 2018 to 2030
- Market estimates and forecast for product segments up to 2030
- Regional market size and forecast for product segments up to 2030
- Market estimates and forecast for application segments up to 2030
- Regional market size and forecast for application segments up to 2030
- Company financial performance
We are committed towards customer satisfaction, and quality service.
"The quality of research they have done for us has been excellent."
Brian Moore, VP, NICCA USA, Inc.
testimonialsMore
